Pulmonary surfactant augments cytotoxicity of silica nanoparticles: Studies on an in vitro air–blood barrier model

Scholarly Works

• Soliman, M. G.; Martinez-Serra, A.; Antonello, G.; Dobricic, M.; Wilkins, T.; Serchi, T.; Fenoglio, I.; Monopoli, M. P. Understanding the role of biomolecular coronas in human exposure to nanomaterials. Environmental science. Nano 2024, 11, 4421–4448. doi:10.1039/d4en00488d
• Kaur, J.; Sharma, A.; Passi, G.; Dey, P.; Khajuria, A.; Alajangi, H. K.; Jaiswal, P. K.; Barnwal, R. P.; Singh, G. Nanomedicine at the Pulmonary Frontier: Immune-Centric Approaches for Respiratory Disease Treatment. Immunological investigations 2024, 53, 295–347. doi:10.1080/08820139.2023.2298398
• Fu, A.; Mao, S.; Kasai, N.; Zhu, H.; Zeng, H. Dynamic tissue model in vitro and its application for assessment of microplastics-induced toxicity to air-blood barrier (ABB). Biosensors & bioelectronics 2023, 246, 115858. doi:10.1016/j.bios.2023.115858
• Sevinc Ozdemir, N.; Belyaev, D.; Castro, M. N.; Balakin, S.; Opitz, J.; Wihadmadyatami, H.; Anggraeni, R.; Yucel, D.; Kenar, H.; Beshchasna, N.; Ana, I. D.; Hasirci, V. Advances in In Vitro Blood-Air Barrier Models and the Use of Nanoparticles in COVID-19 Research. Tissue engineering. Part B, Reviews 2023, 30, 82–96. doi:10.1089/ten.teb.2023.0117
• Breder-Bonk, C.; Docter, D.; Barz, M.; Strieth, S.; Knauer, S. K.; Gül, D.; Stauber, R. H. The Apoptosis Inhibitor Protein Survivin Is a Critical Cytoprotective Resistor against Silica-Based Nanotoxicity. Nanomaterials (Basel, Switzerland) 2023, 13, 2546. doi:10.3390/nano13182546
• Brandão, F.; Costa, C.; Bessa, M. J.; Valdiglesias, V.; Hellack, B.; Haase, A.; Fraga, S.; Teixeira, J. P. Multiparametric in vitro genotoxicity assessment of different variants of amorphous silica nanomaterials in rat alveolar epithelial cells. Nanotoxicology 2023, 17, 511–528. doi:10.1080/17435390.2023.2265481
• Fu, A.; Chang, M.; Zhu, H.; Liu, H.; Wu, D.; Zeng, H. Air-blood barrier (ABB) on a chip. TrAC Trends in Analytical Chemistry 2023, 159, 116919. doi:10.1016/j.trac.2023.116919
• Huck, B.; Hidalgo, A.; Waldow, F.; Schwudke, D.; Gaede, K. I.; Feldmann, C.; Carius, P.; Autilio, C.; Pérez-Gil, J.; Schwarzkopf, K.; Murgia, X.; Loretz, B.; Lehr, C.-M. Systematic Analysis of Composition, Interfacial Performance and Effects of Pulmonary Surfactant Preparations on Cellular Uptake and Cytotoxicity of Aerosolized Nanomaterials. Small Science 2021, 1, 2100067. doi:10.1002/smsc.202100067
• Ferri, C.; Arcangeletti, M. C.; Caselli, E.; Zakrzewska, K.; Maccari, C.; Calderaro, A.; D'Accolti, M.; Soffritti, I.; Arvia, R.; Sighinolfi, G.; Artoni, E.; Giuggioli, D. Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis. Journal of autoimmunity 2021, 124, 102727. doi:10.1016/j.jaut.2021.102727
• Rawal, S.; Patel, M. M. Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers. Nano-micro letters 2021, 13, 142. doi:10.1007/s40820-021-00630-6
• Caruso, G.; Fresta, C. G.; Costantino, A.; Lazzarino, G.; Amorini, A. M.; Lazzarino, G.; Tavazzi, B.; Lunte, S. M.; Dhar, P.; Gulisano, M.; Caraci, F. Lung Surfactant Decreases Biochemical Alterations and Oxidative Stress Induced by a Sub-Toxic Concentration of Carbon Nanoparticles in Alveolar Epithelial and Microglial Cells. International journal of molecular sciences 2021, 22, 2694. doi:10.3390/ijms22052694
• Cao, Y.; Li, S.; Chen, J. Modeling better in vitro models for the prediction of nanoparticle toxicity: a review. Toxicology mechanisms and methods 2020, 31, 1–17. doi:10.1080/15376516.2020.1828521
• Mousseau, F.; Oikonomou, E. K.; Vacher, A.; Airiau, M.; Mornet, S.; Berret, J.-F. Revealing the Pulmonary Surfactant Corona on Silica Nano-particles by Cryo-Transmission Electron Microscopy. Nanoscale advances 2020, 2, 642–647. doi:10.1039/c9na00779b
• Li, J.; Yang, H.; Sha, S.; Li, J.; Zhou, Z.; Cao, Y. Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC. Ecotoxicology and environmental safety 2019, 186, 109770. doi:10.1016/j.ecoenv.2019.109770
• Maretti, E.; Rustichelli, C.; Gualtieri, M. L.; Costantino, L.; Siligardi, C.; Miselli, P.; Buttini, F.; Montecchi, M.; Leo, E.; Truzzi, E.; Iannuccelli, V. The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant. Pharmaceutics 2019, 11, 508–528. doi:10.3390/pharmaceutics11100508
• Garcia-Mouton, C.; Hidalgo, A.; Cruz, A.; Pérez-Gil, J. The Lord of the Lungs: The essential role of pulmonary surfactant upon inhalation of nanoparticles. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 2019, 144, 230–243. doi:10.1016/j.ejpb.2019.09.020
• Osman, N.; Sexton, D. W.; Saleem, I. Toxicological assessment of nanoparticle interactions with the pulmonary system. Nanotoxicology 2019, 14, 21–58. doi:10.1080/17435390.2019.1661043
• Schmitz, C.; Welck, J.; Tavernaro, I.; Grinberg, M.; Rahnenführer, J.; Kiemer, A. K.; van Thriel, C.; Hengstler, J. G.; Kraegeloh, A. Mechanical strain mimicking breathing amplifies alterations in gene expression induced by SiO2 NPs in lung epithelial cells. Nanotoxicology 2019, 13, 1227–1243. doi:10.1080/17435390.2019.1650971
• Schneider-Daum, N.; Hittinger, M.; Murgia, X.; Lehr, C.-M. Cellular and Non-cellular Barriers to Particle Transport Across the Lungs. NanoScience and Technology; Springer International Publishing, 2019; pp 171–189. doi:10.1007/978-3-030-12461-8_7
• Zellnitz, S.; Roblegg, E.; Pinto, J. T.; Fröhlich, E. Delivery of Dry Powders to the Lungs: Influence of Particle Attributes from a Biological and Technological Point of View. Current drug delivery 2019, 16, 180–194. doi:10.2174/1567201815666181024143249

Explore citations to this article at